Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Coverage All age groups Meningococcal disease
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Administration All age groups Meningococcal disease
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
Agenda & Minutes France Typhoid Ebola Human papillomavirus (HPV)
Download:
NITAG recommendation Recommendation Canada Meningococcal disease
Download:
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download:
Economic aspects Efficacy/effectiveness Safety Logistics All age groups Rotavirus